1 – 38 of 38
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Risk of Alzheimer's Disease and Related Dementias in Persons with Glaucoma : A National Cohort Study
2024) In Ophthalmology(
- Contribution to journal › Article
-
Mark
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis
(
- Contribution to journal › Article
-
Mark
How Do Modifiable Risk Factors Affect Alzheimer's Disease Pathology or Mitigate Its Effect on Clinical Symptom Expression?
(
- Contribution to journal › Scientific review
- 2023
-
Mark
Longitudinal Tau PET Using 18F-Flortaucipir : The Effect of Relative Cerebral Blood Flow on Quantitative and Semiquantitative Parameters
2023) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 64(2). p.281-286(
- Contribution to journal › Article
-
Mark
Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer's disease pathogenesis
(
- Contribution to journal › Article
- 2022
-
Mark
Neural network training with highly incomplete medical datasets
(
- Contribution to journal › Article
-
Mark
Tau, bridging the gap between Alzheimer's and Parkinson's diseases
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Developing a Porcine Model to Study the Glymphatic System
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2021
-
Mark
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture
(
- Contribution to journal › Article
-
Mark
Does prolonged education causally affect dementia risk when adult socioeconomic status is not altered? A Swedish natural experiment in 1.3 million individuals
(
- Contribution to journal › Article
- 2020
-
Mark
Kardiovaskulär sjukdom och diabetes typ II som riskfaktorer för kognitiv sjukdom
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Statistical Disease Progression Modeling in Alzheimer Disease
(
- Contribution to journal › Article
-
Mark
Amyloid-β oligomers are captured by the DNAJB6 chaperone : Direct detection of interactions that can prevent primary nucleation
(
- Contribution to journal › Article
-
Mark
Human iPSC-Derived Hippocampal Spheroids : An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies
(
- Contribution to journal › Article
- 2019
-
Mark
Activity-Induced Amyloid-β Oligomers Drive Compensatory Synaptic Rearrangements in Brain Circuits Controlling Memory of Presymptomatic Alzheimer's Disease Mice
(
- Contribution to journal › Article
-
Mark
Alzheimer’s disease not linked to type 2 diabetes or high blood pressure – new study
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
(
- Contribution to journal › Article
- 2018
-
Mark
Sex-specific genetic predictors of Alzheimer’s disease biomarkers
(
- Contribution to journal › Article
- 2017
-
Mark
Microglial cells in Neurodegenerative Diseases. The Role of Galectin-3
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
The effect of white matter hyperintensities on statistical analysis of diffusion tensor imaging in cognitively healthy elderly and prodromal Alzheimer’s disease
(
- Contribution to journal › Article
- 2016
-
Mark
Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia
(
- Contribution to journal › Article
- 2015
-
Mark
The UP-TECH project, an intervention to support caregivers of Alzheimer's disease patients in Italy : Preliminary findings on recruitment and caregiving burden in the baseline population
(
- Contribution to journal › Article
- 2012
-
Mark
Inflammation and neurodegeneration : the story 'retolled'
(
- Contribution to journal › Article
- 2011
-
Mark
Neuropathological findings and staging in dementia
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Detection of Alzheimer peptides and chemokines in the aqueous humor
(
- Contribution to journal › Article
- 2010
-
Mark
Synapses, synaptic activity and intraneuronal Aβ in Alzheimer's disease
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Immunotherapy for Alzheimer disease
(
- Contribution to journal › Article
-
Mark
Synaptic retrogenesis and amyloid-beta in Alzheimer's disease
(
- Contribution to journal › Scientific review
- 2008
-
Mark
Predicting Long-Term Cognitive Outcome with New Regression Models in Donepezil-Treated Alzheimer Patients in a Naturalistic Setting.
(
- Contribution to journal › Article
-
Mark
Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals
(
- Contribution to journal › Article
- 2007
-
Mark
Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly
(
- Contribution to journal › Article
- 2006
-
Mark
The role of cystatin C in cerebral amyloid angiopathy and stroke: Cell biology and animal models : cell biology and animal models
(
- Contribution to journal › Article
- 2005
-
Mark
Evidence-based evaluation of magnetic resonance imaging as a diagnostic tool in dementia workup
(
- Contribution to journal › Scientific review
-
Mark
Prefractionation of cerebrospinal fluid to enhance glycoprotein concentration prior to structural determination with FT-ICR mass spectrometry
(
- Contribution to journal › Article
- 2003
-
Mark
Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease
(
- Contribution to journal › Article
- 2002
-
Mark
Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients
(
- Contribution to journal › Article
- 1994
-
Mark
Neuropsychological tests as discriminators between dementia of Alzheimer type and frontotemporal dementia
(
- Contribution to journal › Article